(CRD-B) Crawford - Ratings and Ratios
Claims, Outsourcing, Risk, Management, Services
CRD-B EPS (Earnings per Share)
CRD-B Revenue
Description: CRD-B Crawford
Crawford & Company is a global provider of claims management and outsourcing solutions, serving insurance carriers, brokers, and corporations across multiple regions, including the United States, the United Kingdom, Europe, Canada, Australia, Asia, and Latin America. With a history dating back to 1941, the company has established itself as a leading player in the industry, offering a broad range of services that cater to the diverse needs of its clients.
The companys comprehensive suite of services includes claims management, field investigation, and the evaluation and resolution of property and casualty insurance claims. Additionally, Crawford & Company provides managed repair services, outsourced contractor management, and staff augmentation, as well as risk management information services and consultative analytical services. Its expertise extends to handling losses caused by natural disasters, such as hurricanes and earthquakes, as well as man-made disasters, like oil spills and explosions.
From a technical analysis perspective, Crawford & Companys stock (CRD-B) is currently trading at $9.97, slightly below its 20-day simple moving average (SMA) of $10.04. The stocks 50-day SMA is $10.20, while its 200-day SMA is $10.86, indicating a potential downtrend. The average true range (ATR) is 0.54, representing a 5.41% volatility. Given the current technical setup, its possible that the stock may continue to consolidate around its current price level before breaking out or down.
Fundamentally, Crawford & Company has a market capitalization of $514.73 million and a price-to-earnings (P/E) ratio of 17.00, which is relatively reasonable compared to its peers. The companys forward P/E ratio is 10.41, suggesting potential earnings growth in the future. With a return on equity (RoE) of 22.48%, Crawford & Company demonstrates a strong ability to generate profits for its shareholders. Based on the current fundamental and technical data, a potential forecast for the stock could be a gradual recovery towards its 50-day SMA, potentially reaching $10.20 in the short term, driven by the companys solid financial performance and industry position.
Looking ahead, Crawford & Companys diversified services and global presence position it for potential long-term growth, particularly as the insurance industry continues to evolve and demand more specialized claims management and outsourcing solutions. As the company continues to expand its offerings and improve its operational efficiency, investors may want to keep a close eye on its financial performance and industry trends to gauge its potential for future growth.
Additional Sources for CRD-B Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CRD-B Stock Overview
Market Cap in USD | 522m |
Sector | Financial Services |
Industry | Insurance Brokers |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 1990-01-12 |
CRD-B Stock Ratings
Growth Rating | 31.9 |
Fundamental | 13.4 |
Dividend Rating | 66.6 |
Rel. Strength | -12 |
Analysts | 5 of 5 |
Fair Price Momentum | 8.73 USD |
Fair Price DCF | 14.94 USD |
CRD-B Dividends
Dividend Yield 12m | 2.80% |
Yield on Cost 5y | 4.71% |
Annual Growth 5y | 10.49% |
Payout Consistency | 82.0% |
Payout Ratio | 32.2% |
CRD-B Growth Ratios
Growth Correlation 3m | -15.6% |
Growth Correlation 12m | -20.2% |
Growth Correlation 5y | 64.8% |
CAGR 5y | 9.41% |
CAGR/Max DD 5y | 0.19 |
Sharpe Ratio 12m | 0.99 |
Alpha | -11.52 |
Beta | 1.181 |
Volatility | 46.10% |
Current Volume | 2.9k |
Average Volume 20d | 2.5k |
Stop Loss | 8.8 (-5.6%) |
As of August 03, 2025, the stock is trading at USD 9.32 with a total of 2,947 shares traded.
Over the past week, the price has changed by -11.24%, over one month by -10.90%, over three months by -10.45% and over the past year by +6.52%.
Neither. Based on ValueRay´s Fundamental Analyses, Crawford is currently (August 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 13.43 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CRD-B is around 8.73 USD . This means that CRD-B is currently overvalued and has a potential downside of -6.33%.
Crawford has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy CRD-B.
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, CRD-B Crawford will be worth about 10.1 in August 2026. The stock is currently trading at 9.32. This means that the stock has a potential upside of +7.94%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 14 | 50.2% |
Analysts Target Price | 14 | 50.2% |
ValueRay Target Price | 10.1 | 7.9% |